Vor Biopharma Statistics
Total Valuation
Vor Biopharma has a market cap or net worth of $24.96 million. The enterprise value is -$4.30 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
Earnings Date | May 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Vor Biopharma has 124.85 million shares outstanding. The number of shares has increased by 22.58% in one year.
Current Share Class | 124.85M |
Shares Outstanding | 124.85M |
Shares Change (YoY) | +22.58% |
Shares Change (QoQ) | +78.26% |
Owned by Insiders (%) | 31.96% |
Owned by Institutions (%) | 11.51% |
Float | 38.95M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.38 |
P/TBV Ratio | 0.38 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.47.
Current Ratio | 3.88 |
Quick Ratio | 3.59 |
Debt / Equity | 0.47 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -125.43% and return on invested capital (ROIC) is -59.97%.
Return on Equity (ROE) | -125.43% |
Return on Assets (ROA) | -55.25% |
Return on Invested Capital (ROIC) | -59.97% |
Return on Capital Employed (ROCE) | -131.93% |
Revenue Per Employee | n/a |
Profits Per Employee | -$745,887 |
Employee Count | 159 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.82% in the last 52 weeks. The beta is -0.21, so Vor Biopharma's price volatility has been lower than the market average.
Beta (5Y) | -0.21 |
52-Week Price Change | -85.82% |
50-Day Moving Average | 0.52 |
200-Day Moving Average | 0.88 |
Relative Strength Index (RSI) | 26.89 |
Average Volume (20 Days) | 5,416,113 |
Short Selling Information
The latest short interest is 2.76 million, so 2.21% of the outstanding shares have been sold short.
Short Interest | 2.76M |
Short Previous Month | 1.11M |
Short % of Shares Out | 2.21% |
Short % of Float | 7.08% |
Short Ratio (days to cover) | 1.40 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -122.15M |
Pretax Income | -118.09M |
Net Income | -118.60M |
EBITDA | -118.74M |
EBIT | -122.15M |
Earnings Per Share (EPS) | -$1.43 |
Full Income Statement Balance Sheet
The company has $60.04 million in cash and $30.78 million in debt, giving a net cash position of $29.25 million or $0.23 per share.
Cash & Cash Equivalents | 60.04M |
Total Debt | 30.78M |
Net Cash | 29.25M |
Net Cash Per Share | $0.23 |
Equity (Book Value) | 66.07M |
Book Value Per Share | 0.53 |
Working Capital | 48.12M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$100.26 million and capital expenditures -$346,000, giving a free cash flow of -$100.61 million.
Operating Cash Flow | -100.26M |
Capital Expenditures | -346,000 |
Free Cash Flow | -100.61M |
FCF Per Share | -$0.81 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Vor Biopharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.58% |
Shareholder Yield | -22.58% |
Earnings Yield | -475.19% |
FCF Yield | -403.11% |
Analyst Forecast
The average price target for Vor Biopharma is $7.20, which is 3,501.80% higher than the current price. The consensus rating is "Buy".
Price Target | $7.20 |
Price Target Difference | 3,501.80% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |